Steven Hildemann, M.D., Ph.D.

Steven Hildemann, M.D., Ph.D. joined Ipsen in March 2020 as Chief Medical Officer.

Prior to joining Ipsen, Steven held leadership roles in science-based bioethics and built an innovative digital health startup in cancer care after serving for five years as Chief Medical Officer, Senior Vice President, Head of Global Medical Affairs and Global Patient Safety at Merck. He also held several strategic leadership positions with biopharmaceutical companies such as Pharmacia-Pfizer and Schering-Plough-MSD.

Steven is board certified in internal medicine and cardiology with broad clinical training across internal medicine including medical oncology, gastroenterology, rheumatology and pulmonary oncology at university hospitals in Munich, Germany. Throughout his career, he has engaged in part-time clinical practice, late-stage pharmaceutical research and medical teaching. Steven received his M.D., Ph.D. at the Albert Ludwig University of Freiburg, Germany, where he continues to serve as an adjunct Professor of Medicine.